510(k) K262816
K262816 is an FDA 510(k) premarket notification submitted by Cb Innovations, LLC for the device "EXG PulseLinQ Cables (EXGPL)". The FDA issued a decision of Substantially Equivalent on Oct 30, 2026. The device falls under product code DSA (Cable, Transducer And Electrode, Patient, (Including Connector)), a Class II device regulated under 21 CFR 870.2900.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 30, 2026
- Date Received
- Aug 7, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Cable, Transducer And Electrode, Patient, (Including Connector)
- Device Class
- Class II
- Regulation Number
- 870.2900
- Review Panel
- CV
- Submission Type
- 510(k)
Need the full FDA record for Cb Innovations, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.